agalsidase beta (Q20801779)

From Wikidata

Jump to navigation Jump to search

pharmaceutical drug

• Alpha-D- galactoside galactohydrolase
• Alpha-D-galactosidase A
• Alpha-galactosidase A precursor
• Agalsidase alfa
• Melibiase

edit

Language	Label	Description	Also known as
English	agalsidase beta	pharmaceutical drug	Alpha-D- galactoside galactohydrolase Alpha-D-galactosidase A Alpha-galactosidase A precursor Agalsidase alfa Melibiase

Statements

instance of

type of chemical entity

0 references

subclass of

alpha-glucosidase

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148806

retrieved

27 February 2018

has use

medication

1 reference

title

Agalsidase beta (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00103

defined daily dose

5.0 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=A16AB04

active ingredient in

Fabrazyme

1 reference

European Medicines Agency product number

EMEA/H/C/000370

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000370/human_med_000784.jsp

retrieved

22 March 2017

Replagal

1 reference

European Medicines Agency product number

EMEA/H/C/000369

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000369/human_med_001029.jsp

retrieved

22 March 2017

medical condition treated

Fabry disease

2 references

stated in

NDF-RT

NDF-RT ID

N0000148806

language of work or name

English

retrieved

13 December 2016

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

lipid storage disease

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

has characteristic

biopharmaceutical

1 reference

title

Agalsidase beta (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00103

Identifiers

CAS Registry Number

104138-64-9

1 reference

stated in

DrugBank

DrugBank ID

00103

language of work or name

English

title

Agalsidase beta (English)

publication date

17 November 2015

ChEMBL ID

CHEMBL2108888

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL2108888

language of work or name

English

title

Agalsidase beta (English)

retrieved

19 January 2016

DSSTox substance ID

DTXSID80883136

0 references

ATC code

A16AB04

1 reference

stated in

DrugBank

DrugBank ID

00103

language of work or name

English

title

Agalsidase beta (English)

publication date

17 November 2015

RxNorm ID

338817

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148806

retrieved

26 February 2018

DrugBank ID

DB00103

0 references

UNII

RZD65TSM9U

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148806

language of work or name

English

title

AGALSIDASE BETA (English)

retrieved

19 January 2016

2HLC17MX9G

0 references

NDF-RT ID

N0000148806

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148806

language of work or name

English

title

AGALSIDASE BETA (English)

retrieved

19 January 2016

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q20801779&oldid=2190021187"